Rett Syndrome Research Trust Awards a Record $10.3 Million in 2023 to Advance a Cure for Rett Syndrome

The Rett Syndrome Research Trust (RSRT) continues to spearhead groundbreaking research in its pursuit of a cure for Rett syndrome. RSRT has announced an investment of $10.3 million in 2023 to highly innovative research projects, bringing together leading scientists, institutions, and...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: VEN Source Type: news